Crimson - i2b2 integration for high-throughput, scalable sample collection

Crimson - i2b2 集成,用于高通量、可扩展的样本收集

基本信息

  • 批准号:
    7918185
  • 负责人:
  • 金额:
    $ 44.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Lack of well-phenotype samples remains a key bottleneck in biomedical research. The costs associated with collection often exceed those associated with any other step in the discovery process. The Crimson application addresses these issues by enabling high-throughput, cost-effective collection of samples for IRB-approved studies by (1) real-time query of discarded samples from Clinical Laboratories and (2) leveraging cohorts generated with i2b2's tools (Informatics for Integrating Biology to the Bedside). Crimson's use with i2b2 has significantly reduced costs associated with sample collection for investigators, often by 1-2 orders of magnitude, while also increasing the throughput of materials available to IRB-approved studies. We believe full integration of Crimson as an i2b2 cell will further promulgate these capabilities at both local and national levels. We propose to develop Crimson vocabularies to increase its interoperability within the i2b2 infrastructure, further design and develop means for distributed queries enabling high-throughput sample collection across institutions, and develop and test an economic model of Crimson's impact upon a research enterprise for studies using Crimson within i2b2 to enable high-throughput sample collection for large-scale research studies.
描述(由申请人提供): 缺乏表型良好的样本仍然是生物医学研究的一个关键瓶颈。与收集相关的成本通常超过与发现过程中任何其他步骤相关的成本。Crimson应用程序解决了这些问题,通过(1)实时查询临床实验室丢弃的样本和(2)利用i2 b2工具(用于将生物学整合到床边的信息学)生成的队列,为IRB批准的研究实现高通量、经济高效的样本收集。Crimson与i2 b2的结合使用显着降低了研究人员的样本收集相关成本,通常降低了1-2个数量级,同时还增加了IRB批准的研究可用材料的吞吐量。我们相信,Crimson作为i2 b2单元的全面集成将进一步在地方和国家层面推广这些功能。我们建议开发Crimson词汇表,以提高其在i2 b2基础设施内的互操作性,进一步设计和开发分布式查询的方法,从而实现跨机构的高通量样本收集,并开发和测试Crimson对研究企业的影响的经济模型,以便在i2 b2内使用Crimson进行研究,从而实现大规模研究的高通量样本收集。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LYNN BRY其他文献

LYNN BRY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LYNN BRY', 18)}}的其他基金

NMR-resolved dynamics of C. difficile metabolism
艰难梭菌代谢的核磁共振解析动力学
  • 批准号:
    10574895
  • 财政年份:
    2022
  • 资助金额:
    $ 44.5万
  • 项目类别:
Commensal control of C. difficile virulence
艰难梭菌毒力的共生控制
  • 批准号:
    10334540
  • 财政年份:
    2021
  • 资助金额:
    $ 44.5万
  • 项目类别:
Commensal control of C. difficile virulence
艰难梭菌毒力的共生控制
  • 批准号:
    10211712
  • 财政年份:
    2021
  • 资助金额:
    $ 44.5万
  • 项目类别:
Commensal control of C. difficile virulence
艰难梭菌毒力的共生控制
  • 批准号:
    10556405
  • 财政年份:
    2021
  • 资助金额:
    $ 44.5万
  • 项目类别:
Epithelial Glycoconjugates as Barriers against Enteric Infections
上皮糖复合物作为肠道感染的屏障
  • 批准号:
    8511759
  • 财政年份:
    2009
  • 资助金额:
    $ 44.5万
  • 项目类别:
Crimson - i2b2 integration for high-throughput, scalable sample collection
Crimson - i2b2 集成,用于高通量、可扩展的样本收集
  • 批准号:
    7698313
  • 财政年份:
    2009
  • 资助金额:
    $ 44.5万
  • 项目类别:
Epithelial Glycoconjugates as Barriers against Enteric Infections
上皮糖复合物作为肠道感染的屏障
  • 批准号:
    8114180
  • 财政年份:
    2009
  • 资助金额:
    $ 44.5万
  • 项目类别:
Epithelial Glycoconjugates as Barriers against Enteric Infections
上皮糖复合物作为肠道感染的屏障
  • 批准号:
    8304230
  • 财政年份:
    2009
  • 资助金额:
    $ 44.5万
  • 项目类别:
Epithelial Glycoconjugates as Barriers against Enteric Infections
上皮糖复合物作为肠道感染的屏障
  • 批准号:
    8239799
  • 财政年份:
    2009
  • 资助金额:
    $ 44.5万
  • 项目类别:
Epithelial Glycoconjugates as Barriers against Enteric Infections
上皮糖复合物作为肠道感染的屏障
  • 批准号:
    7932782
  • 财政年份:
    2009
  • 资助金额:
    $ 44.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了